Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 963-969

  Nam, Robert K ^a,d   Saskin, Refik ^c   Lee, Yuna ^b   Liu, Ying ^c   Law, Calvin ^a,d   Klotz, Laurence H ^a   Loblaw, D Andrew ^a   Trachtenberg, John ^c   Stanimirovic, Aleksandra ^a   Simor, Andrew E ^a   Seth, Arun ^a   Urbach, David R ^c,d   Narod, Steven A ^d  

^a Sunnybrook Health Sciences Centre   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

adverse effects; biopsy; mass screening; prostatic neoplasms

Indexed keywords

ARTICLE; CANADA; CAUSE OF DEATH; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT DISEASE; URINARY TRACT HEMORRHAGE; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSTATE; RECTUM; RETROSPECTIVE STUDIES; UROLOGIC DISEASES;

EID: 75849131676     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.11.043     Document Type: Article

References (17)

1. Hodge K.K., McNeal J.E., and Stamey T.A. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 142 (1989) 66
2. Terris M.K. Ultrasonography and biopsy of the prostate. In: Walsh P.C., Retik A.B., Vaughan E.D., et al. (Eds). Campbell's Urology. 8th ed. vol. 4 (2002), Saunders, Philadelphia 3038-3054
3. Kapoor D.A., Klimberg I.W., Malek G.H., et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52 (1998) 552
4. Aron M., Rajeev T.P., and Gupta N.P. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85 (2000) 682
5. Ghani K.R., Dundas D., and Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int 94 (2004) 1014
6. Sieber P.R., Rommel F.M., Theodoran C.G., et al. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 70 (2007) 498
7. Feliciano J., Teper E., Ferrandino M., et al. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis?. J Urol 179 (2008) 952
8. Raaijmakers R., Kirkels W.J., Roobol M.J., et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60 (2002) 826
9. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613
10. Lee G., Attar K., Laniado M., et al. Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 39 (2007) 185
11. Jeon S.S., Woo S.H., Hyun J.H., et al. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology 62 (2003) 461
12. Laupland K.B., Ross T., Pitout J.D., et al. Community-onset urinary tract infections: a population-based assessment. Infection 35 (2007) 150
13. de la Taille A., Antiphon P., Salomon L., et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 61 (2003) 1181
14. Presti Jr. J.C., Chang J.J., Bhargava V., et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163 (2000) 163
15. Roehrborn C.G., Nuckolls J.G., Wei J.T., et al. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics. BJU Int 100 (2007) 813
16. Giannarini G., Mogorovich A., Valent F., et al. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology 70 (2007) 501
17. Begg C.B., Riedel E.R., Bach P.B., et al. Variations in morbidity after radical prostatectomy. N Engl J Med 346 (2002) 1138